ABSTRACT
The use of NovaSure under local anaesthesia (LA) has been described as part of efficacy trials, but its use in an outpatient setting has not previously been explored. This prospective study was conducted to determine feasibility and efficacy of NovaSure in the outpatient setting under LA. The study included all women with menorrhagia unresponsive to medical management and were agreeable for treatment under LA (nâ=â50). The mean duration of procedure was 100 s. A total of 47 (94%) patients were discharged home the same day. Simple analgesics controlled postoperative pain in 44 (88%) patients. Seven (14%) patients gave preference for general anaesthesia for future treatment. The mean pain scores at 30, 60 and 90 min were 4.18, 4.38 and 3.85, respectively on the visual analogue scale. At follow-up, the improvement in menstrual symptoms was seen in 47 (94%) and the satisfaction rate was 43 (86%) and 47 (94%) at 4 and 6 months, respectively.
